Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients
Author:
Affiliation:
1. Department of Internal Medicine (IV), Osaka Medical College, Takatsuki, Osaka, Japan;
2. Department of Rheumatology, Internal Medicine, Yodogawa Christian Hospital, Osaka, Japan
Publisher
Oxford University Press (OUP)
Subject
Rheumatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1318468
Reference26 articles.
1. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases
2. Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis
3. Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients
4. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib;Internal Medicine;2024-09-15
2. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial;BMJ Case Reports;2024-06
3. Clinical utility of anti-Ro52 antibody confirmation in anti-MDA5 antibody-positive dermatomyositis: A case report;Modern Rheumatology Case Reports;2024-05-16
4. Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia;Virology Journal;2024-03-26
5. Combination therapy with methylprednisolone, rituximab, and tofacitinib in antimelanoma differentiation‐associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease;Rheumatology & Autoimmunity;2024-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3